Impact of hyperprolactinemia in a patient with polyautoimmunity

Hyperprolactinemia has been proposed as a triggering factor for autoimmune diseases. The increased levels of prolactin could induce an abnormal immune response. Herein, we present a patient with hyperprolactinemia who developed polyautoimmunity. Patient's symptoms were associated with slightly...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
2019
Institución:
Universidad del Rosario
Repositorio:
Repositorio EdocUR - U. Rosario
Idioma:
eng
OAI Identifier:
oai:repository.urosario.edu.co:10336/23677
Acceso en línea:
https://doi.org/10.1002/ccr3.1900
https://repository.urosario.edu.co/handle/10336/23677
Palabra clave:
Acetylsalicylic acid
Bromocriptine
Cabergoline
Deflazacort
Hydroxychloroquine
Immunoglobulin g
Immunoglobulin m
Adult
Alopecia
Amenorrhea
Antiphospholipid syndrome
Article
Autoimmunity
Body weight loss
Case report
Clinical article
Female
Follow up
Hair loss
Human
Hyperprolactinemia
Mouth ulcer
Nuclear magnetic resonance imaging
Priority journal
Rash
Raynaud phenomenon
Serology
Sjoegren syndrome
Systemic lupus erythematosus
Hyperprolactinemia
Prolactin
Sjögren's syndrome
Systemic lupus erythematosus
Rights
License
Abierto (Texto Completo)
id EDOCUR2_e7bdd5c1ce63b460e9879e455eacd9de
oai_identifier_str oai:repository.urosario.edu.co:10336/23677
network_acronym_str EDOCUR2
network_name_str Repositorio EdocUR - U. Rosario
repository_id_str
spelling 1110541485600102296173560052483526600194747786002020-05-26T00:04:20Z2020-05-26T00:04:20Z2019Hyperprolactinemia has been proposed as a triggering factor for autoimmune diseases. The increased levels of prolactin could induce an abnormal immune response. Herein, we present a patient with hyperprolactinemia who developed polyautoimmunity. Patient's symptoms were associated with slightly raised levels of prolactin (20-40 ng/mL) and administration of dopaminergic agonists. © 2018 The Authors. Clinical Case Reports published by John Wiley and Sons Ltd.application/pdfhttps://doi.org/10.1002/ccr3.190020500904https://repository.urosario.edu.co/handle/10336/23677engWiley-Blackwell Publishing Ltd23No. 119Clinical Case ReportsVol. 7Clinical Case Reports, ISSN:20500904, Vol.7, No.1 (2019); pp. 19-23https://www.scopus.com/inward/record.uri?eid=2-s2.0-85056324360&doi=10.1002%2fccr3.1900&partnerID=40&md5=3e733d6f5afa5065aa9c001e33afa4b2Abierto (Texto Completo)http://purl.org/coar/access_right/c_abf2instname:Universidad del Rosarioreponame:Repositorio Institucional EdocURAcetylsalicylic acidBromocriptineCabergolineDeflazacortHydroxychloroquineImmunoglobulin gImmunoglobulin mAdultAlopeciaAmenorrheaAntiphospholipid syndromeArticleAutoimmunityBody weight lossCase reportClinical articleFemaleFollow upHair lossHumanHyperprolactinemiaMouth ulcerNuclear magnetic resonance imagingPriority journalRashRaynaud phenomenonSerologySjoegren syndromeSystemic lupus erythematosusHyperprolactinemiaProlactinSjögren's syndromeSystemic lupus erythematosusImpact of hyperprolactinemia in a patient with polyautoimmunityarticleArtículohttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501Rojas Quintana, Manuel EduardoRodríguez Velandia, Yhojan AlexisRamírez Santana, Heily CarolinaAnaya, Juan-Manuel10336/23677oai:repository.urosario.edu.co:10336/236772022-05-02 07:37:16.636813https://repository.urosario.edu.coRepositorio institucional EdocURedocur@urosario.edu.co
dc.title.spa.fl_str_mv Impact of hyperprolactinemia in a patient with polyautoimmunity
title Impact of hyperprolactinemia in a patient with polyautoimmunity
spellingShingle Impact of hyperprolactinemia in a patient with polyautoimmunity
Acetylsalicylic acid
Bromocriptine
Cabergoline
Deflazacort
Hydroxychloroquine
Immunoglobulin g
Immunoglobulin m
Adult
Alopecia
Amenorrhea
Antiphospholipid syndrome
Article
Autoimmunity
Body weight loss
Case report
Clinical article
Female
Follow up
Hair loss
Human
Hyperprolactinemia
Mouth ulcer
Nuclear magnetic resonance imaging
Priority journal
Rash
Raynaud phenomenon
Serology
Sjoegren syndrome
Systemic lupus erythematosus
Hyperprolactinemia
Prolactin
Sjögren's syndrome
Systemic lupus erythematosus
title_short Impact of hyperprolactinemia in a patient with polyautoimmunity
title_full Impact of hyperprolactinemia in a patient with polyautoimmunity
title_fullStr Impact of hyperprolactinemia in a patient with polyautoimmunity
title_full_unstemmed Impact of hyperprolactinemia in a patient with polyautoimmunity
title_sort Impact of hyperprolactinemia in a patient with polyautoimmunity
dc.subject.keyword.spa.fl_str_mv Acetylsalicylic acid
Bromocriptine
Cabergoline
Deflazacort
Hydroxychloroquine
Immunoglobulin g
Immunoglobulin m
Adult
Alopecia
Amenorrhea
Antiphospholipid syndrome
Article
Autoimmunity
Body weight loss
Case report
Clinical article
Female
Follow up
Hair loss
Human
Hyperprolactinemia
Mouth ulcer
Nuclear magnetic resonance imaging
Priority journal
Rash
Raynaud phenomenon
Serology
Sjoegren syndrome
Systemic lupus erythematosus
Hyperprolactinemia
Prolactin
Sjögren's syndrome
Systemic lupus erythematosus
topic Acetylsalicylic acid
Bromocriptine
Cabergoline
Deflazacort
Hydroxychloroquine
Immunoglobulin g
Immunoglobulin m
Adult
Alopecia
Amenorrhea
Antiphospholipid syndrome
Article
Autoimmunity
Body weight loss
Case report
Clinical article
Female
Follow up
Hair loss
Human
Hyperprolactinemia
Mouth ulcer
Nuclear magnetic resonance imaging
Priority journal
Rash
Raynaud phenomenon
Serology
Sjoegren syndrome
Systemic lupus erythematosus
Hyperprolactinemia
Prolactin
Sjögren's syndrome
Systemic lupus erythematosus
description Hyperprolactinemia has been proposed as a triggering factor for autoimmune diseases. The increased levels of prolactin could induce an abnormal immune response. Herein, we present a patient with hyperprolactinemia who developed polyautoimmunity. Patient's symptoms were associated with slightly raised levels of prolactin (20-40 ng/mL) and administration of dopaminergic agonists. © 2018 The Authors. Clinical Case Reports published by John Wiley and Sons Ltd.
publishDate 2019
dc.date.created.spa.fl_str_mv 2019
dc.date.accessioned.none.fl_str_mv 2020-05-26T00:04:20Z
dc.date.available.none.fl_str_mv 2020-05-26T00:04:20Z
dc.type.eng.fl_str_mv article
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.type.spa.spa.fl_str_mv Artículo
dc.identifier.doi.none.fl_str_mv https://doi.org/10.1002/ccr3.1900
dc.identifier.issn.none.fl_str_mv 20500904
dc.identifier.uri.none.fl_str_mv https://repository.urosario.edu.co/handle/10336/23677
url https://doi.org/10.1002/ccr3.1900
https://repository.urosario.edu.co/handle/10336/23677
identifier_str_mv 20500904
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.citationEndPage.none.fl_str_mv 23
dc.relation.citationIssue.none.fl_str_mv No. 1
dc.relation.citationStartPage.none.fl_str_mv 19
dc.relation.citationTitle.none.fl_str_mv Clinical Case Reports
dc.relation.citationVolume.none.fl_str_mv Vol. 7
dc.relation.ispartof.spa.fl_str_mv Clinical Case Reports, ISSN:20500904, Vol.7, No.1 (2019); pp. 19-23
dc.relation.uri.spa.fl_str_mv https://www.scopus.com/inward/record.uri?eid=2-s2.0-85056324360&doi=10.1002%2fccr3.1900&partnerID=40&md5=3e733d6f5afa5065aa9c001e33afa4b2
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.rights.acceso.spa.fl_str_mv Abierto (Texto Completo)
rights_invalid_str_mv Abierto (Texto Completo)
http://purl.org/coar/access_right/c_abf2
dc.format.mimetype.none.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Wiley-Blackwell Publishing Ltd
institution Universidad del Rosario
dc.source.instname.spa.fl_str_mv instname:Universidad del Rosario
dc.source.reponame.spa.fl_str_mv reponame:Repositorio Institucional EdocUR
repository.name.fl_str_mv Repositorio institucional EdocUR
repository.mail.fl_str_mv edocur@urosario.edu.co
_version_ 1808390783138529280

Publicaciones similares